Clinical trial

Molecular Fingerprinting of Lung Cancer

Name
VICC THO 0136
Description
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer. PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.
Trial arms
Trial start
2001-05-01
Estimated PCD
2031-05-31
Trial end
2031-05-31
Status
Recruiting
Treatment
gene expression analysis
Blood and lung tissue collection
Arms:
Resectable non-small cell lung cancer
microarray analysis
Blood and lung tissue collection
Arms:
Resectable non-small cell lung cancer
protein expression analysis
Blood and lung tissue collection
Arms:
Resectable non-small cell lung cancer
biologic sample preservation procedure
Blood and lung tissue collection
Arms:
Resectable non-small cell lung cancer
laboratory biomarker analysis
Blood and lung tissue collection
Arms:
Resectable non-small cell lung cancer
matrix-assisted laser desorption/ionization time of flight mass spectrometry
Blood and lung tissue collection
Arms:
Resectable non-small cell lung cancer
Size
4000
Primary endpoint
Protein and RNA expression fingerprints from collected samples
after collection of designated samples
Eligibility criteria
Inclusion criteria * Diagnosis of non-small cell lung cancer * Clinical stage I and II disease * Resectable disease and complete surgical resection planned * Treated on companion studies at Vanderbilt University, the Veterans Administration hospital, St. Thomas, and Vanderbilt-Ingram Cancer Center Affiliate Network * Tumor specimen samples must be available at resection Exclusion criteria * Chemotherapy before surgery * Radiotherapy before surgery
Protocol
{'studyType': 'OBSERVATIONAL', 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'bioSpec': {'retention': 'SAMPLES_WITH_DNA', 'description': 'Both prospective and retrospectives samples of blood and tissue.'}, 'enrollmentInfo': {'count': 4000, 'type': 'ESTIMATED'}}
Updated at
2024-05-22

1 organization

3 products

1 indication

Indication
lung cancer